Helping couples communicate better to improve step-count prescriptions for people with type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial enrolls people with type 2 diabetes who live with a partner to compare two approaches for increasing daily steps. All participants and their partners receive step counters and a SMARTER step-prescription program; half the couples are randomized to also receive a dyadic coping (communication) intervention. Investigators will track step counts over time, collect baseline and follow-up measures, and record a couple conversation to analyze communication styles. Eligible participants are age 45 or older, cohabiting for at least two years, able to walk, and must have smartphone and internet access; the trial is conducted at McGill-affiliated hospitals in Montreal.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* (i) Index participant has T2D;
* (ii) Index participant 45 years of age or older;
* (iii) Index participant and partner: Co-habiting with a partner (same or different sex) for two or more years;
* (iv) Index participant and partner: Absence of gait difficulties or other co-morbid conditions that impede walking in the index participant;
* (v) Willingness to complete an audiovisual recording of a conversation between the couple members to capture couple communication styles
* (vi) Index participant and partner Smartphone and Internet access.

Where it's running

• McGill University Health Centre
  Montreal, Quebec, Canada Recruiting
• St. Mary's Hospital
  Montreal, Quebec, Canada Not yet recruiting
• Jewish General Hospital
  Montreal, Quebec, Canada Not yet recruiting

Study contacts

• Principal investigator: Kaberi Dasgupta, MDCM, MSc, FRCPC — Research Institute of the McGill University Health Centre
• Study coordinator: Debora Rosa, BSc
• Email: debora.rosa@rimuhc.ca
• Phone: 1-438-346-0479

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Acute Blood Flow Restriction Walking in Type 2 Diabetes

  This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.

  Recruiting University of British Columbia · Kelowna, British Columbia · NCT07928531

• Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin

  This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.

  Recruiting Medical University of Bialystok · Bialystok · NCT07919236

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

• Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses

  This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.

  Recruiting at 2 sites German Institute of Human Nutrition · Berlin and 1 other locations · NCT07888257

• Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar

  This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.

  Recruiting German Institute of Human Nutrition · Potsdam, Potsdam-Rehbrücke · NCT07868601

• Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes

  This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.

  Recruiting at 2 sites Phase 1 Novo Nordisk A/S · Glendale, California and 1 other locations · NCT07868354

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.